loading page

Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti-angiogenic therapy
  • +2
  • Mouadh Nefiss,
  • Hichem Abid,
  • Mohamed Amine Gharbi,
  • Ramzi Bouzidi ,
  • Anis Teborbi
Mouadh Nefiss
University Hospital Center Mongi Slim

Corresponding Author:[email protected]

Author Profile
Hichem Abid
University Hospital Center Mongi Slim
Author Profile
Mohamed Amine Gharbi
University Hospital Center Mongi Slim
Author Profile
Ramzi Bouzidi
University Hospital Center Mongi Slim
Author Profile
Anis Teborbi
University Hospital Center Mongi Slim
Author Profile

Abstract

Management of bone metastases from renal cell carcinoma (RCC) has significantly changed after the era of targeted therapy that improved the overall survival (OS).Surgical decision-making remains a subject of controversy.We report a case of pelvic bone metastasis from RCC, 2 months after nephrectomy and surgery of a revealing clavicular metastasis
03 Oct 2021Submitted to Clinical Case Reports
07 Oct 2021Submission Checks Completed
07 Oct 2021Assigned to Editor
25 Oct 2021Reviewer(s) Assigned
09 Jan 2022Review(s) Completed, Editorial Evaluation Pending
09 Jan 2022Editorial Decision: Revise Minor
18 Jan 20221st Revision Received
19 Jan 2022Submission Checks Completed
19 Jan 2022Assigned to Editor
19 Jan 2022Review(s) Completed, Editorial Evaluation Pending
25 Jan 2022Editorial Decision: Accept
Nov 2022Published in Clinical Case Reports volume 10 issue 11. 10.1002/ccr3.6599